Company
Hemispherian
An entirely new way of treating cancer
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Develops a novel class of small molecule drugs (GLIX) as an epigenetic therapy for particularly aggressive cancers.
Loading relationship preview